Vimarsana
Biggest News Aggregation in the World

Study Outcomes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Outcomes Today - Breaking & Trending Today

First Phase 3 TREMFYA® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis - Vimarsana News

First Phase 3 TREMFYA® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis

Published: May 9, 2023

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new efficacy and safety data from the Phase 3 QUASAR Induction Study...

Source: prnewswire.com
Related Topics:
Spring HouseBritish ColumbiaUnited StatesCraig StoltzJessicar AllegrettiNational Institutes Of HealthJanssen Pharmaceutical Companies Of JohnsonNone Of The Janssen Pharmaceutical CompaniesCompanies Of JohnsonJanssen Research DevelopmentAmerican Society For Gastrointestinal EndoscopyCenters For DiseaseCrohn Colitis FoundationAmerican Gastroenterological AssociationCrohn Colitis Foundation Of AmericaExchange CommissionColitis CenterJanssen Pharmaceutical CompaniesSociety For Surgery Of The Alimentary TractDigestive DiseaseAnnual MeetingMedical DirectorStudy OutcomesAbout Digestive DiseaseAmerican Association
Johnson & Johnson : First Phase 3 TREMFYA® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis - Vimarsana News

Johnson & Johnson : First Phase 3 TREMFYA® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis

Published: May 9, 2023

That cause chronic inflammation of the gastrointestinal tract.6 Prolonged inflammation results in damage to the GI tract.6 The exact cause of IBD is unknown but may be the result of the immune... | May 9, 2023

Source: marketscreener.com
Related Topics:
United StatesSpring HouseJessicar AllegrettiCraig StoltzNational Institutes Of HealthColitis CenterCrohn Colitis Foundation Of AmericaAmerican Society For Gastrointestinal EndoscopyExchange CommissionSociety For Surgery Of The Alimentary TractCenters For DiseaseJanssen Pharmaceutical CompaniesNone Of The Janssen Pharmaceutical CompaniesJanssen Pharmaceutical Companies Of JohnsonAmerican Gastroenterological AssociationJanssen Research DevelopmentCrohn Colitis FoundationCompanies Of JohnsonDigestive DiseaseAnnual MeetingMedical DirectorStudy OutcomesAbout Digestive DiseaseAmerican AssociationLiver Diseases
Assessing losses | Beef Magazine - Vimarsana News

Assessing losses | Beef Magazine

Published: August 2, 2022

Many dairies are adding a cross breeding program to add value to newborn calves, however it's not always as easy as it sounds.

Source: beefmagazine.com
Related Topics:
Study Outcomes